 BioNTech SE - ADR NASDAQ: BNTX shares are trading higher by 5.37 to 136.45 going into the close of Wednesdays trading session after the FDA granted Emergency Use Authorization to the companys 10-μg booster dose of an Omicron BA.4BA.5-adapted bivalent COVID-19 vaccine. 